妊娠合并糖尿病孕妇对自我血糖监测建议的依从性与围产期结局
这项单中心前瞻性队列研究纳入2015年12月至2018年6月期间入组孕周小于29周的2型糖尿病和妊娠期糖尿病孕妇103例,使用云端自我血糖监测技术评估对每日4次血糖检测建议的依从性。2型糖尿病孕妇平均依从率51%,妊娠期糖尿病A1级66%、A2级70%(P=.016)。依从性每增加10%,剖宫产、新生儿低血糖和大于胎龄儿的 odds 降低15-20%,子痫前期无关联。
要点
- 2型糖尿病孕妇血糖监测依从率51%,低于妊娠期糖尿病A1级66%和A2级70%(P=.016)。
- 依从性每增加10%,剖宫产、新生儿低血糖、大于胎龄儿的 odds 降低15-20%。
- 依从性与子痫前期发生率无关联。
核心结论
- 对血糖检测建议的总体依从性因糖尿病类型而异,并与新生儿结局相关。
- 依从性提高带来的结局改善可能反映根据实时血糖值更及时地调整药物。
- 旨在提高依从性的项目可能有益。
研究设计与样本
- 单中心前瞻性队列研究,纳入2015年12月至2018年6月期间入组孕周小于29周的2型糖尿病和妊娠期糖尿病孕妇103例。
- 所有孕妇使用蜂窝网络血糖仪,将血糖值实时上传至云端、符合《健康保险流通与责任法案》的平台。
- 主要结局为对自我血糖监测建议的依从性,建议每日4次血糖检测,计算依从百分比。
- 次要结局为子痫前期、剖宫产、大于胎龄儿和新生儿低血糖。
- 研究效能设定为检测不同糖尿病类型间主要结局依从性10%的差异,使用逻辑回归生成校正风险比和95%置信区间。
主要发现
- 2型糖尿病孕妇初始糖化血红蛋白和体重指数高于妊娠期糖尿病孕妇,年龄和产次无差异。
- 2型糖尿病孕妇依从性计算覆盖20±6周,妊娠期糖尿病孕妇为9±4周。
- 2型糖尿病孕妇总体依从性显著低于妊娠期糖尿病孕妇,平均检测依从率分别为51%、66%(A1级)和70%(A2级)(P=.016)。
- 依从性每增加10%,剖宫产、新生儿低血糖和大于胎龄儿的 odds 降低15-20%。
- 依从性与子痫前期发生率无关联。
关键数值与推荐
- 建议每日4次血糖检测,依从百分比按此计算。
- 主要结局为对自我血糖监测建议的依从性。
- 次要结局包括子痫前期、剖宫产、大于胎龄儿和新生儿低血糖。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Self-glucose monitoring is critical for the management of diabetes mellitus in pregnancy; yet, validated reports of adherence to testing recommendations and associated perinatal outcomes are limited. OBJECTIVE: Using cloud-based, self-glucose monitoring technology, we sought to answer the following questions: (1) Are there differences in the rates of testing adherence based on type of diabetes mellitus in pregnancy? (2) Is adherence to glucose monitoring recommendations associated with perinatal outcomes in pregnancies that are complicated by diabetes mellitus? We hypothesized that adherence to glucose testing recommendations varies by type of diabetes mellitus and that increased adherence to testing recommendations would be associated with improved perinatal outcomes. STUDY DESIGN: This single-center, prospective cohort study included women with type 2 diabetes mellitus and gestational diabetes mellitus who were enrolled in a perinatal diabetes program at <29 weeks gestation between December 2015 and June 2018. All women received a cellular-enabled glucometer that uploaded glucose values to a cloud-based, Health Insurance Portability and Accountability Act-compliant platform in real time that ensured transmission of accurate glucose values. The primary outcome was adherence to self-glucose monitoring recommendations. Four glucose checks were advised daily, and percentage of adherence was calculated. Secondary outcomes were preeclampsia, cesarean delivery, large-for-gestational-age neonates, and neonatal hypoglycemia. The study was powered to detect a 10% difference in the primary outcome of adherence to advised self-glucose monitoring by diabetes mellitus type. Adjusted risk ratios and 95% confidence intervals were generated with the use of logistic regression. RESULTS: This study included 103 eligible women. Baseline characteristics differed between groups, with women with type 2 diabetes mellitus having higher initial HgbA1c and body mass index when compared with women with gestational diabetes mellitus. No differences were noted in age or parity. Adherence was calculated over 20±6 weeks for women with type 2 diabetes mellitus compared with 9±4 weeks for women with gestational diabetes mellitus. Overall adherence to glucose monitoring was significantly less for women with type 2 diabetes mellitus compared with those with gestational diabetes mellitus. Mean testing adherence rates were 51%, 66%, and 70% for type 2 diabetes mellitus, and gestational diabetes mellitus, class A1 and A2, respectively (P=.016). We found that, for every 10% increase in adherence to testing recommendations, the odds of cesarean delivery, neonatal hypoglycemia, and large-for-gestational-age fetuses decreases by 15-20%. There was no association between adherence and rates of preeclampsia. CONCLUSION: This study shows that overall adherence to testing recommendations differs by diabetes mellitus type and is associated with neonatal outcomes. Improved outcomes with higher adherence may reflect more timely medication adjustments in response to real-time glucose values. Programs aimed at improving adherence could prove beneficial.
引用
- Wernimont SA, Sheng JS, Tymkowicz A, et al. Adherence to self-glucose monitoring recommendations and perinatal outcomes in pregnancies complicated by diabetes mellitus. Am J Obstet Gynecol MFM. 2019. PMID: 33345801. doi:10.1016/j.ajogmf.2019.100031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。